You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

niraparib

Showing 51 - 75 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Hong Kong (Niraparib)

Recruiting
  • Ovarian Cancer
  • Niraparib
  • Hong Kong, Hong Kong
    The University of Hong Kong
Sep 27, 2021

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Microsatellite

Recruiting
  • Advanced Microsatellite Stable Colorectal Carcinoma
  • +5 more
  • Niraparib
  • Panitumumab
  • Atlanta, Georgia
  • +2 more
Oct 29, 2021

Ovarian Cancer Trial in Wuhan (Niraparib)

Recruiting
  • Ovarian Cancer
  • Niraparib
  • Wuhan, Hubei, China
    Tongji Hospital
Oct 21, 2021

Advanced Solid Tumor, Breast Cancer Trial (Niraparib, M4344)

Withdrawn
  • Advanced Solid Tumor
  • Breast Cancer
  • (no location specified)
Jun 24, 2021

Urothelial Carcinoma Trial in Italy (Niraparib, Best supportive care)

Completed
  • Urothelial Carcinoma
  • Niraparib
  • Best supportive care
  • Alba, Italy
  • +19 more
May 16, 2022

Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)

Active, not recruiting
Has Results
  • Ovarian Neoplasms
  • Niraparib
  • Bevacizumab
  • Mobile, Alabama
  • +27 more
Nov 23, 2022

Niraparib Maintenance Treatment in Newly Diagnosed Ovarian

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Niraparib
  • (no location specified)
Jul 23, 2021

Breast Cancer, Ovarian Cancer Trial in Sioux Falls (niraparib, everolimus)

Active, not recruiting
  • Breast Cancer
  • Ovarian Cancer
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Aug 24, 2021

Ovarian Cancer Trial in Beijing, Jinan (Niraparib)

Recruiting
  • Ovarian Cancer
  • Niraparib
  • Beijing, China
  • +1 more
Aug 27, 2021

Breast Cancer Trial (RP-6306, Gemcitabine, Observation)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 26, 2023

Ovarian Cancer Trial in Denmark, Finland, Norway (Niraparib, Bevacizumab, TSR042)

Withdrawn
  • Ovarian Cancer
  • Niraparib
  • +4 more
  • Copenhagen, Sjaelland, Denmark
  • +7 more
Jul 9, 2021

Solid Tumor, Adult, Homologous Recombination Deficiency Trial in Washington, Hackensack, Charlotte (Niraparib, Carboplatin)

Recruiting
  • Solid Tumor, Adult
  • Homologous Recombination Deficiency
  • Washington, District of Columbia
  • +2 more
Aug 31, 2021

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)

Recruiting
  • Glioblastoma
  • +2 more
  • Niraparib
  • +2 more
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Jul 16, 2021

Endometrial Cancer Trial in Canada (Niraparib, TSR-042)

Active, not recruiting
  • Endometrial Cancer
  • Calgary, Alberta, Canada
  • +6 more
Nov 18, 2021

Advanced Malignant Solid Tumor, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Los Angeles

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Atezolizumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 7, 2022

Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Niraparib
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Aug 3, 2022

Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers Trial (Niraparib)

Not yet recruiting
  • Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
  • Niraparib
  • (no location specified)
Feb 21, 2022

OVARIAN CANCER Trial in Worldwide (Cobimetinib, Niraparib, Atezolizumab)

Recruiting
  • OVARIAN CANCER
  • Tucson, Arizona
  • +28 more
Jan 10, 2023

Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

Recruiting
  • Lung Small Cell Carcinoma
  • +5 more
  • Dostarlimab
  • Niraparib
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

HER2-negative Metastatic Breast Cancer Trial in Nashville (DAN-222, Niraparib)

Recruiting
  • HER2-negative Metastatic Breast Cancer
  • Nashville, Tennessee
    Sarah Cannon Research Institute/Tennessee Oncology
Feb 25, 2022

Ovarian Cancer Trial in Italy (Niraparib, Dostarlimab, Pegylated liposomal doxorubicin)

Recruiting
  • Ovarian Cancer
  • Niraparib
  • +6 more
  • Brescia, Italy
  • +7 more
Aug 24, 2021

Ovarian Cancer Trial in Villejuif (AsiDNA, Niraparib, Olaparib)

Recruiting
  • Ovarian Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Sep 27, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Japan (Niraparib)

Active, not recruiting
Has Results
  • Ovarian Cancer
  • +2 more
  • Niraparib
  • Nagoya, Aichi, Japan
  • +26 more
Feb 7, 2022